Home >  News >  February, 2014

Local Analgesic Reduces Post-Bariatric Opioids

Study explores Exparel's use in managing abdominal surgery pain.

Published: February 3, 2014

A multimodal pain management therapy that includes the non-opioid local analgesic Exparel lessens the need for post-op narcotics after bariatric surgery, according to a recent study.

For the study, Andras Sandor, MD, FACS, FASMBS, and colleagues at the Hallmark Health Center for Weight Management and Weight Loss Surgery in Medford, Mass., observed the pain management regimens of 90 patients undergoing laparoscopic bariatric procedures.

Half of the patients received a multimodal approach to post-op pain management, including Pacira Pharmaceutical's bupivacaine liposome injectable suspension drug, Exparel, infiltrated into the transversus abdominis plane (a process known as iTAP). The other half were given ketorolac and a lidocaine and bupivacaine/epinephrine combination perioperatively, and pain pumps of hydromorphone afterward.

Each group was allowed opioids at 2 days post-op. But the multimodal group consumed 60.7% fewer opioids. Additionally, they exhibited a greater return of bowel function at the 2-day mark. Dr. Sandor and his team presented their findings at the American Society for Metabolic & Bariatric Surgery's 2013 Obesity Week in November.

"The risks of opioids are pronounced in the bariatric population; utilizing a non-opioid platform with Exparel iTAP at its foundation contributed to decreasing both the amount of opioids needed and their resultant opioid-related adverse effects," says Dr. Sandor.

David Bernard


Also in the News...

New Orleans Surgeon Avoids Video Voyeurism Charges
Compounding Pharmacy Owner Barry Cadden Acquitted of Murder
Study Finds Mobile App Follow-ups as Effective as In-Person Visits
Another Patient Death Raises Question: Is Gluteal Fat Grafting Safe?
Bill Would Eliminate Medicare Co-Pays for Polyp Removal During Colonoscopies
Former Head of Sales Testifies NECC President Knew His Company Was to Blame for Tainted Steroids Outbreak
The Program Is Set for OR Excellence 2017

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Leftover Opioids May Play Significant Role in Crisis

TJC Defends Its Pain Management Standards

The organization notes that opioid prescriptions were already on the rise before it released requirements for treating patients' pain.

Post-op Pain in 2016

Our reader survey shows continued migration from opioids, toward multimodal.